NCT00195026|Completed
Loading search results
Sponsor study identifier
observational
200
1 country
1
Study Start
March 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThis protocol will evaluate a new non-invasive infrared imaging system as an adjunctive tool for breast cancer detection that has been approved by the FDA. The technology and device have been developed by Infrared Sciences Corp. and has undergone more than 3 years of testing prior. The subject device's utility will be investigated with regard to its sensitivity toward breast cancer, however it records temperature data and other physiological parameters of the breast, and compares them to a database of patients with known breast health.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 14, 2005
Actual (reported)September 19, 2005
Actual (reported)Patients already scheduled for breast biopsies will receive an additional infrared scan
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients already recommended for breast biopsy
Weill Cornell Breast Center
New York, New York, 10021, United States
Michael Osborne, MD
NY Presbyterian Hospital Weill Cornell Breast Center
First Submitted
September 14, 2005
First Posted
September 19, 2005
Study Start
March 2005
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
March 18, 2008
Record last verified: 2008-03
High Risk Screening Breast MR Using a Rapid Imaging Exam
Contact the study team to confirm eligibility.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: